About script

At Script Bioscience, our team is driven by a shared mission to unlock the next generation of RNA-based therapeutics. Blending deep expertise in synthetic biology, molecular engineering, and drug development, we are united in our pursuit to solve some of the most challenging problems in medicine. Script Biosciences was founded with a singular focus of developing curative therapies by safely and effectively correcting disease pathologies arising from mutations in the genome. Our therapeutic approach is grounded in the synergy of two cutting-edge platform technologies: a CRISPR-based gene editing system (CasPlus) and a specialized family of engineered lipid nanoparticle carriers. These vehicles facilitate targeted cargo delivery to vital organs such as the brain, pancreas, or lungs, forming the cornerstone of our treatment strategy.